Keyphrases
Risk Reduction
100%
Hospitalized Patients
100%
Diabetic Ketoacidosis
100%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Clinical Trials
25%
Non-associated
25%
Patient Care
25%
Type 2 Diabetes Mellitus (T2DM)
25%
Patient Education
25%
Early Treatment
25%
Self-management
25%
Blood Glucose
25%
Normal Blood
25%
Heart Disease
25%
Kidney Disease
25%
Potential Risk
25%
Acute Disease
25%
Medication Management
25%
Heart-kidney
25%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetic Ketoacidosis
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Clinical Trial
12%
Kidney Disease
12%
Heart Disease
12%
Acute Disease
12%
Nursing and Health Professions
Patient Care
12%
Non Insulin Dependent Diabetes Mellitus
12%
Patient Education
12%
Self Care
12%
Glucose Blood Level
12%
Heart Disease
12%
Kidney Disease
12%
Acute Disease
12%
Medication Therapy Management
12%